These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 25968593

  • 1. Mid-regional pro-atrial natriuretic peptide and blood pressure in adolescents: effect of gender and pubertal stage.
    Goharian TS, Gimsing AN, Goetze JP, Faber J, Andersen LB, Grøntved A, Jeppesen JL.
    Blood Press; 2015; 24(6):347-52. PubMed ID: 25968593
    [Abstract] [Full Text] [Related]

  • 2. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S, Hansen TW, Goetze JP, Rossing P.
    Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
    [Abstract] [Full Text] [Related]

  • 3. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J, Potocki M, Murray K, Breidthardt T, Ziller R, Mosimann T, Klima T, Hoeller R, Moehring B, Sou SM, Rubini Gimenez M, Morgenthaler NG, Mueller C.
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [Abstract] [Full Text] [Related]

  • 4. Associations of Proatrial Natriuretic Peptide with Components of the Metabolic Syndrome in Adolescents and Young Adults from the General Population.
    Goharian TS, Goetze JP, Faber J, Andersen LB, Grøntved A, Jeppesen JL.
    Am J Hypertens; 2017 Jun 01; 30(6):561-568. PubMed ID: 28338810
    [Abstract] [Full Text] [Related]

  • 5. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone.
    Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Müller J, Skakkebaek NE, Heiman ML, Birkett M, Attanasio AM, Kiess W, Rascher W.
    J Clin Endocrinol Metab; 1997 Sep 01; 82(9):2904-10. PubMed ID: 9284717
    [Abstract] [Full Text] [Related]

  • 6. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 7. Intensive Lifestyle Intervention Increases Plasma Midregional Proatrial Natriuretic Peptide Concentrations in Overweight Children.
    Thomsen CF, Goharian TS, Larsen KT, Goetze JP, Andersen LB, Jeppesen JL.
    J Am Heart Assoc; 2021 Jul 06; 10(13):e020676. PubMed ID: 34180245
    [Abstract] [Full Text] [Related]

  • 8. [High levels of atrial natriuretic peptide and copeptin and mortality risk].
    Rey C, García-Cendón C, Martínez-Camblor P, López-Herce J, Concha-Torre A, Medina A, Vivanco-Allende A, Mayordomo-Colunga J.
    An Pediatr (Barc); 2016 Dec 06; 85(6):284-290. PubMed ID: 26988235
    [Abstract] [Full Text] [Related]

  • 9. Serum proatrial natriuretic peptide concentrations during oral glucose-induced acute hyperinsulinemia in lean and obese men.
    Asferg CL, Nielsen SJ, Andersen UB, Linneberg A, Goetze JP, Jeppesen JL.
    Peptides; 2019 Jan 06; 111():98-102. PubMed ID: 29524563
    [Abstract] [Full Text] [Related]

  • 10. Copeptin and MR-proADM in umbilical cord plasma reflect perinatal stress in neonates born to mothers with diabetes and MR-proANP reflects maternal diabetes.
    Smith J, Halse KG, Damm P, Lindegaard ML, Amer-Wåhlin I, Hertel S, Johansen M, Mathiesen ER, Nielsen LB, Goetze JP.
    Biomark Med; 2013 Feb 06; 7(1):139-46. PubMed ID: 23387495
    [Abstract] [Full Text] [Related]

  • 11. Obese Hypertensive Men Have Lower Circulating Proatrial Natriuretic Peptide Concentrations Despite Greater Left Atrial Size.
    Asferg CL, Andersen UB, Linneberg A, Goetze JP, Jeppesen JL.
    Am J Hypertens; 2018 May 07; 31(6):645-650. PubMed ID: 29471357
    [Abstract] [Full Text] [Related]

  • 12. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Zabarovskaja S, Hage C, Linde C, Daubert JC, Donal E, Gabrielsen A, Mellbin L, Lund LH.
    Int J Cardiol; 2015 May 07; 189():6-11. PubMed ID: 25885866
    [Abstract] [Full Text] [Related]

  • 13. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E, Brueckmann M, Lang S, Kälsch T, Haghi D, Sueselbeck T, Dempfle CE, Borggrefe M.
    Int J Cardiol; 2008 Aug 18; 128(2):244-9. PubMed ID: 17673312
    [Abstract] [Full Text] [Related]

  • 14. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
    Krüger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T, CAPNETZ Study Group.
    Thorax; 2010 Mar 18; 65(3):208-14. PubMed ID: 20335288
    [Abstract] [Full Text] [Related]

  • 15. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T.
    J Card Fail; 2007 Feb 18; 13(1):42-9. PubMed ID: 17339002
    [Abstract] [Full Text] [Related]

  • 16. Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease.
    von Haehling S, Papassotiriou J, Hartmann O, Doehner W, Stellos K, Geisler T, Wurster T, Schuster A, Botnar RM, Gawaz M, Bigalke B.
    Clin Sci (Lond); 2012 Nov 18; 123(10):601-10. PubMed ID: 22690794
    [Abstract] [Full Text] [Related]

  • 17. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study.
    Vazquez M, Jockers K, Christ-Crain M, Zimmerli W, Müller B, Schuetz P.
    Int J Cardiol; 2012 Apr 05; 156(1):16-23. PubMed ID: 21093937
    [Abstract] [Full Text] [Related]

  • 18. Mid-regional pro-atrial natriuretic peptide and the assessment of volaemic status and differential diagnosis of profound hyponatraemia.
    Nigro N, Winzeler B, Suter-Widmer I, Schuetz P, Arici B, Bally M, Blum CA, Nickel CH, Bingisser R, Bock A, Rentsch Savoca K, Huber A, Müller B, Christ-Crain M.
    J Intern Med; 2015 Jul 05; 278(1):29-37. PubMed ID: 25418365
    [Abstract] [Full Text] [Related]

  • 19. Natriuretic pro-peptides in idiopathic intracranial hypertension.
    Skau M, Goetze JP, Rehfeld JF, Jensen R.
    Regul Pept; 2010 Sep 24; 164(2-3):71-7. PubMed ID: 20553977
    [Abstract] [Full Text] [Related]

  • 20. Atrial plasma ANP and NH2-terminal proANP during right atrial pressure increase in humans.
    Arjamaa O, Karlqvist K, Vainionpää V, Leppäluoto J, Vuolteenaho O.
    Acta Physiol Scand; 1996 Aug 24; 157(4):481-5. PubMed ID: 8869731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.